摘要
目的分析并研究低分子肝素治疗胎儿生长受限的临床应用效果。方法将104例胎儿生长受限的患者分为观察组和对照组,每组各52例。对照组采用低分子右旋糖酐配合丹参治疗,观察组采用低分子右旋糖酐配合低分子肝素治疗,比较两组患儿的临床疗效。结果观察组患儿的宫高情况、股骨长、胎儿双顶径、腹围以及头围均明显优于对照组,观察组胎儿的生物物理评分明显优于对照组,脐动脉血流速度等情况明显低于对照组,新生儿的体重情况高于对照组,差异有统计学意义(P<0.05)。结论低分子肝素可改善胎盘血流量,能够促进胎儿增长,可有效治疗胎儿生长受限,且对于胎儿和母体均较安全。
Objective To analysis and research the clinical effect of low mole-cular heparin therapy on fetal growth re- striction （FGR）. Methods 104 patients with FGR were randomly divided into the observation group and the control group.Each group included 52 cases.The control group was treated with low molecular dextran and danshen,and the ob- servation group was treated with low molecular de-xtran conbined with low molecular heparin.The effects of the two groups were compared. Results The height of fundus of uterus,femur length,hiparietal diameters,abdominal perimeter and head circumference in the observation group were better than those in the control group.The biophysical score and the iudexs of the speed blow of umbilical arteries in the observation group were also better than those in the control group.The body weight of newborn of the observation were higher than that of the control group. Conclusion Low molecular heparin improve placents function,promote fetal growth,have good effects on FGR,which is safe for both preg- nant and their fetuses.
出处
《中国当代医药》
2014年第7期55-56,59,共3页
China Modern Medicine
关键词
低分子肝素
胎儿生长受限
低分子右旋糖酐
Low molecular heparin
Fetal growth restriction
Low molecular dextran
